Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort

The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of HIV viremia in patients living with HIV (PLWH) who switch to two-drug antiretroviral therapy (2DR) containing lamivudine (3TC) (2DR-3TC-based). A retros...

Description complète

Détails bibliographiques

Auteurs principaux:	Vincenzo Malagnino, Romina Salpini, Elisabetta Teti, Mirko Compagno, Ludovica Ferrari, Tiziana Mulas, Valentina Svicher, Marta Zordan, Monica Basso, Giuliana Battagin, Sandro Panese, Maria Cristina Rossi, Renzo Scaggiante, Daniela Zago, Marco Iannetta, Saverio Giuseppe Parisi, Massimo Andreoni, Loredana Sarmati
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-01-01
Collection:	Viruses
Sujets:	HIV/HBV 2DR HBcAb hepatitis B virus (HBV) Occult Hepatitis B Infection (OBI)
Accès en ligne:	https://www.mdpi.com/1999-4915/15/1/193
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!